000 | 01996 a2200505 4500 | ||
---|---|---|---|
005 | 20250514052052.0 | ||
264 | 0 | _c20021217 | |
008 | 200212s 0 0 eng d | ||
022 | _a1077-4114 | ||
024 | 7 |
_a10.1097/00043426-200211000-00016 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCrews, Kristine R | |
245 | 0 | 0 |
_aPharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure. _h[electronic resource] |
260 |
_bJournal of pediatric hematology/oncology _cNov 2002 |
||
300 |
_a677-80 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aAspergillosis _xcomplications |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCladribine _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFatal Outcome |
650 | 0 | 4 | _aHemofiltration |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeukapheresis |
650 | 0 | 4 |
_aLeukemia, Monocytic, Acute _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 |
_aUrate Oxidase _xtherapeutic use |
700 | 1 | _aWimmer, Peggy S | |
700 | 1 | _aHudson, Joanna Q | |
700 | 1 | _aHoward, Scott C | |
700 | 1 | _aRibeiro, Raul C | |
700 | 1 | _aRazzouk, Bassem I | |
773 | 0 |
_tJournal of pediatric hematology/oncology _gvol. 24 _gno. 8 _gp. 677-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00043426-200211000-00016 _zAvailable from publisher's website |
999 |
_c12245771 _d12245771 |